Showing 431-440 of 7170 results for "".
DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitFive ways marketing can fight the winter practice doldrums
https://practicaldermatology.com/topics/practice-management/five-ways-marketing-can-fight-the-winter-practice-doldrums/20036/The holiday season creeps up on us earlier and earlier each year. Let’s resolve to be prepared! You can fight the slow season and winter doldrums by marketing to what makes this time of the year so special. There no longer has to be a slowdown. You can be busy year-round – and that is reason to cele6-Plus Ways to Promote New Devices, Innovative Treatments
https://practicaldermatology.com/topics/practice-management/6-plus-ways-to-promote-new-devices-innovative-treatments/23587/There are many ways to use digital tools like email, social media, and video to promote your services.DERM2021: An Engaging Learning Experience
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-engaging-learning-experience/19967/Joe Gorelick, MSN, FNP-BC, DEF President, is excited for this year’s DERM2021 NP/PA CME Conference that offers meaningful case studies presented by an advisory panel of dermatology nurse practitioners and physician assistants for an engaging learning experience.DERM2021: The Right Meeting For All Derm PAs/NPs
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-the-right-meeting-for-all-derm-pasnps/19964/Kristine Kucera, PA-C, MPAS, DHS says all dermatology physician assistants and nurse practitioners should be attending this year’s DERM2021 NP/PA CME Conference. She discusses the unique educational opportunities and access to top-notch presenters available at this meeting.Managing Skin Disease in Cancer Patients
https://practicaldermatology.com/topics/skin-cancer-photoprotection/managing-skin-disease-in-cancer-patients/19927/Skin reactions to cancer therapeutics can lead to difficult-to-manage rashes. Biologics can present an effective, appropriate option, but dermatologists need to know which biologics to select and when. Anisha Patel, MD provides an overview.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.SARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Dermatology SEO trend alert: voice search
https://practicaldermatology.com/topics/practice-management/dermatology-seo-trend-alert-voice-search/19883/One of the hottest trends in internet search is voice-powered technology. What does that mean for your dermatology website? Watch this short video from Ekwa Marketing to find out.Long-term efficacy and safety data from ILUMYA™ clinical trials
https://practicaldermatology.com/topics/psoriasis/long-term-efficacy-and-safety-data-from-ilumya-clinical-trials/19858/Explore efficacy and safety data for ILUMYA™ from the reSURFACE 1 and reSURFACE 2 Phase 3 trials and extension studies.